Theraclion and Furui Medical Form JV to Market HIFU Surgical Device in China

Theraclion of France formed a China joint venture with Inner Mongolia Furui Medical Science to market Theraclion's HIFU surgery device. The Echopulse® is a non-invasive medical device employing ultrasound-guided high-intensity focused ultrasound (HIFU) to treat non-cancerous tumors -- breast fibroadenoma and benign thyroid nodules -- in an out-patient procedure. The JV, which will be based in Shenzhen, will be 56% owned by Theraclion China. Furui will own the rest. More details.... Stock Symbols: (Alternext: FR0010120402) (SHZ: 300049) Share this with colleagues: // //